See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $9.3B | 7.6x | 21.7x | |
| $7.8B | n/a | n/a | |
| $2.5B | 9.4x | -598.0x | |
| $1.2B | 4.3x | -10.0x | |
| $1.0B | n/a | n/a | |
| $408M | n/a | n/a | |
| $372M | 178.1x | -11.7x | |
| $140M | 43.8x | -6.9x | |
| $139M | n/a | -2.1x | |
| $132M | 2.5x | 13.9x | |
| $117M | 6.8x | 8.9x | |
| $86.4M | 10.0x | -4.4x | |
| $59.1M | 3.3x | 17.5x | |
| $55.2M | 2.0x | n/a | |
| $48.4M | 18.7x | -9.8x | |
| $28.8M | 32.4x | -12.3x | |
| $1.6M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics